TEVA-BUDESONIDE
TEVA-BUDESONIDE
Approved
DIN Number
02465949
Drug Class
Human
Market Date
Nov 8, 2017
Company
HC
teva canada limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02465949
AIG Number0116807005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA02 BUDESONIDE
Product Specifications
Dosage FormSuspension
Route of AdministrationInhalation
AHFS Classification68:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BUDESONIDEActive
Strength: 0.125 MG / ML
Monograph: BUDESONIDE